Exploring the language used to describe older patients at multidisciplinary cancer conferences

Kim, Valerie S.; Carrozzi, Anthony; Papadopoulos, Efthymios; Tejero, Isabel; Thiruparanathan, Thirisangi; Perlis, Nathan; Hope, Andrew J.; Jang, Raymond W.; Alibhai, Shabbir

doi:http://dx.doi.org/10.3390/cancers16081477

Exploring the language used to describe older patients at multidisciplinary cancer conferences

License

Citation

Kim VS, Carrozzi A, Papadopoulos E, Tejero I, Thiruparanathan T, Perlis N, et al. Exploring the language used to describe older patients at multidisciplinary cancer conferences. Cancers (Basel). 2024 Apr 12;16(8):1477. DOI: 10.3390/cancers16081477

Abstract

Older adults with cancer often present with distinct complexities that complicate their care, yet the language used to discuss their management at multidisciplinary cancer conferences (MCCs) remains poorly understood. A mixed methods study was conducted at a tertiary cancer centre in Toronto, Canada, where MCCs spanning five tumour sites were attended over six months. For presentations pertaining to a patient aged 75 or older, a standardized data collection form was used to record their demographic, cancer-related, and non-cancer-related information, as well as the presenter's specialty and training level. Descriptive statistics and thematic analysis were employed to explore MCC depictions of older patients (n = 75). Frailty status was explicitly mentioned in 20.0% of presentations, but discussions more frequently referenced comorbidity burden (50.7%), age (33.3%), and projected treatment tolerance (30.7%) as surrogate measures. None of the presentations included mentions of formal geriatric assessment (GA) or validated frailty tools; instead, presenters tended to feature select GA domains and subjective descriptions of appearance ("looks to be fit") or overall health ("relatively healthy"). In general, MCCs appeared to rely on age-focused language that may perpetuate ageism. Further work is needed to investigate how frailty and geriatric considerations can be objectively incorporated into discussions in geriatric oncology.